SEC Info  
   Home     Search     My Interests     Help     Sign In     Please Sign In  

Mimedx Group, Inc. · 8-K · For 6/26/13

Filed On 6/26/13, 3:16pm ET   ·   Accession Number 1140361-13-26400   ·   SEC File 1-35887

  in   Show  and 
Help... Wildcards:  ? (any letter),  * (many).  Logic:  for Docs:  & (and),  | (or);  for Text:  | (anywhere),  "(&)" (near).
 
  As Of                Filer                Filing    For/On/As Docs:Size              Issuer               Agent

 6/26/13  Mimedx Group, Inc.                8-K:5       6/26/13    1:14K                                    Thomson Reuters Accelus

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Mimedx Group Inc 8-K 6-26-2013                      HTML     11K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934
 
Date of Report (date of earliest event reported): June 26, 2013
 
MIMEDX GROUP, INC.
(Exact name of registrant as specified in charter)
 
Florida
26-2792552
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

1775 West Oak Commons Court NE
Marietta, GA
(Address of principal executive offices)
30062
(Zip Code)
 
(770) 651-9100
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Directors; Compensatory Arrangements of Certain Officers.
 
(b) Steve Gorlin has resigned as a member of the Board of Directors of MiMedx Group, Inc., in order to devote more time to other interests, effective June 26, 2013.
 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated:  June 26, 2013
MIMEDX GROUP, INC
 
 
 
 
 
By:
/s/: Michael J. Senken
 
 
 
Michael J. Senken, Chief Financial Officer
 
 
 
2

Dates Referenced Herein   and   Documents Incorporated By Reference

This 8-K Filing   Date   Other Filings
Filed On / Filed As Of / For The Period Ended6/26/13
 
TopList All Filings


Filing Submission 0001140361-13-026400   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2014 Fran Finnegan & Company.  All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue, 16 Sep 19:25:38.0 GMT